The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 23, 2007
Filed:
Dec. 04, 2001
Sergey A. Lukyanov, Moscow, RU;
Arcady F. Fradkov, Moscow, RU;
Yulii A. Labas, Moscow, RU;
Mikhail V. Matz, Palm Coast, FL (US);
Alexey Terskikh, Palo Alto, CA (US);
Sergey A. Lukyanov, Moscow, RU;
Arcady F. Fradkov, Moscow, RU;
Yulii A. Labas, Moscow, RU;
Mikhail V. Matz, Palm Coast, FL (US);
Alexey Terskikh, Palo Alto, CA (US);
Clontech Laboratories, Inc., Mountain View, CA (US);
Abstract
Nucleic acid compositions encoding novel chromo/fluoroproteins and mutants thereof, as well as the encoded proteins, are provided. The subject proteins of interest are proteins that are colored and/or fluorescent, where this feature arises from the interaction of two or more residues of the protein. The subject proteins are further characterized in that they are either obtained from non-bioluminescent, e.g., Anthozoan, species or are obtained from non-Pennatulacean (sea pen) species. Specific proteins of interest include proteins obtained from the following specific Anthozoan species:(NFP-1),sp. (NFP-2),sp. (NFP-3 & NFP-4),(NFP-5),sp. 'red'(NFP-6),(NFP-7),sp 'green' (NFP-8), andsp. “magenta” (NFP-9). Also interest are proteins that are substantially similar to, or mutants of, the above specific proteins. Also provided are fragments of the nucleic acids and the peptides encoded thereby, as well as antibodies to the subject proteins and transgenic cells and organisms. The subject protein and nucleic acid compositions find use in a variety of different applications. Finally, kits for use in such applications, e.g., that include the subject nucleic acid compositions, are provided.